drugset / Trial / NCT01484951

AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure

NCT01484951

Phase 4 Completed 74 enrolled Alcon Research
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to assess the safety and efficacy of switching to Azarga from prior pharmacotherapy in patients with open-angle glaucoma.

Timeline

Start
2011-05
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule 1 % Other
Subject Timolol Other / unclassified 0.5 % Other

Indications